Medication shortages are affecting many hospitals – we’re low/out of prochlorperazine, injectable metaclopromide, etomidate, propofol, brevital – and one of the replacements we’ve recently been introduced to is “Propoven”, a European manufacture of propofol.
It has only minor differences from propofol, but it should be noted it requires strict sterile technique when handling and has more medium-chain fatty acids. An informational letter from Kabi describing a few of the differences is here: